Abstract: Described herein relates to a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: Described herein relates to a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: The present disclosure pertains to an anhydrous topical composition for retarding and/or inhibiting scarring of a wound, burn and/or skin condition located on the skin of a subject. Additionally, the topical composition may comprise the following: MCT, monolaurin, cetyl esters, marine oil, vegetable oil having an omega 3 fatty acid content greater than 9 wt %, and/or rice bran wax.

Abstract: Disclosed is a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: Disclosed is a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: Disclosed herein relates to compositions of and methods for the treatment of skin damage and/or wounds, while simultaneously relieving pain and/or cosmetic damage. As such, the present disclosure relates to an anhydrous topical composition for retarding and/or inhibiting scarring of a wound, burn and/or skin condition located on the skin of a subject while retaining a natural characteristic and/or elasticity of the skin. The anhydrous topical composition may comprise MCT, monolaurin, cetyl esters, marine oil, vegetable oil having an omega 3 fatty acid content greater than 9 wt %, and/or hempseed oil. Additionally, the anhydrous topical composition may comprise antimicrobial properties and/or characteristics, such that the anhydrous topical composition may be configured to inhibit any pathogen (e.g., a bacteria, a virus, a fungus, etc.) within the wound, burn and/or skin condition, when applied to the skin of the subject.

Abstract: Disclosed is a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: Disclosed is a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: Disclosed is a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: The present disclosure describes a novel anhydrous topical pharmaceutical composition comprised of marine oil, such as fish oil or algae oil; vegetable oil having a an omega3 fat content greater than 9 wt %, such as hempseed oil, canola oil, flax seed oil, or cannabidiol; monolaurin, cetyl esters or wax; and medium chain triglycerides (“MCT”), and optionally fish collagen. The composition is useful for treating wounds, burns and skin conditions.

Abstract: Disclosed is a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: The present disclosure is directed to a treatment system in a lagoon containing water that promotes the formation of biologically active granules that digest sludge in the lagoon, the lagoon comprising a bottom thereof, the water of the lagoon having a surface layer, the system including X number of water circulators in a cluster having an impeller disposed in the lagoon, wherein X is greater than or equal to three and hydraulic walls formed from at least some of the water expelled from each of a given pair of adjacent water circulators, wherein each of the hydraulic walls intersects at the midpoint of any two adjacent circulators, said hydraulic wall redirecting the expelled water downward towards the bottom of the lagoon, wherein the hydraulic walls at least partially surround at least one circulator.

Abstract: In one embodiment, hydrodynamic cavitation lyses influent bacteria, releasing intracellular enzymes, and creates CaCO3 seed crystals that are discharged at the base of the water column. Bottom-dwelling upflow anaerobic sludge blanket (UASB)-like granules grow in a dense, viscous N, P & Ca++ rich fluid (“hydrolytic brine”). The brine hydrolyzes ancient sludge and fresh solids into simple liquids. The granules convert hydrolyzed liquids into gas. New CaCO3 seeds grow at the produced gas/supernatant interface and propagate across the entire lagoon. Once the sludge inventory is digested, there is an excess of granules that modulate their gross productivity in response to substrate load, pH, and temperature. In one specific example, the treated lagoon has no odor, is free of gelled sludge and effluent.

Abstract: The present invention relates to a topical pharmaceutical composition comprising povidone-iodine, a tertiary amide, surfactant and coconut oil, useful for killing microbes and treating wounds or sores on the surface of the skin.

Abstract: In one embodiment, a method of reducing at least one of nitrogen, carbon and phosphorous in a lagoon that includes at least three cells.

Abstract: Disclosed is a method of reducing the rancid fish odor smell in a topical composition comprised of fish oil which comprises mixing the composition with monolaurin. Also disclosed are various anhydrous topical compositions comprising fish oil. One comprises fish oil, cetyl ester, palm olein, medium-chain triglyceride(s) of a mixture of C8 and C10 fatty acids, mixture of C8/C10 fatty acids, and monolaurin, another one comprises fish oil, cetyl ester, palm olein, medium-chain triglyceride(s) of a mixture of C8 and C10 fatty acids, mixture of C8/C10 fatty acids, monolaurin, collagen and sea salt, an a third one comprises fish oil, cetyl ester, palm olein, medium-chain triglyceride(s) of a mixture of C8 and C10 fatty acids, mixture of C8/C10 fatty acids, monolaurin and hydrocolloid. These compositions are useful for treating wounds and skin conditions.

Abstract: In one embodiment, a method of reducing at least one of nitrogen, carbon and phosphorous in a lagoon that includes at least three cells.

Abstract: In one embodiment, hydrodynamic cavitation lyses influent bacteria, releasing intracellular enzymes, and creates CaCO3 seed crystals that are discharged at the base of the water column. Bottom-dwelling upflow anaerobic sludge blanket (UASB)-like granules grow in a dense, viscous N, P & Ca++ rich fluid (“hydrolytic brine”). The brine hydrolyzes ancient sludge and fresh solids into simple liquids. The granules convert hydrolyzed liquids into gas. New CaCO3 seeds grow at the produced gas/supernatant interface and propagate across the entire lagoon. Once the sludge inventory is digested, there is an excess of granules that modulate their gross productivity in response to substrate load, pH, and temperature.

Abstract: Disclosed is a method of reducing the rancid fish odor smell in a topical composition comprised of fish oil which comprises mixing the composition with monolaurin. Also disclosed are various anhydrous topical compositions comprising fish oil. One comprises fish oil, cetyl ester, palm olein, medium-chain triglyceride(s) of a mixture of C8 and C10 fatty acids, mixture of C8/C10 fatty acids, and monolaurin, another one comprises fish oil, cetyl ester, palm olein, medium-chain triglyceride(s) of a mixture of C8 and C10 fatty acids, mixture of C8/C10 fatty acids, monolaurin, collagen and sea salt, an a third one comprises fish oil, cetyl ester, palm olein, medium-chain triglyceride(s) of a mixture of C8 and C10 fatty acids, mixture of C8/C10 fatty acids, monolaurin and hydrocolloid. These compositions are useful for treating wounds and skin conditions.

Abstract: The present invention relates to a topical pharmaceutical composition comprising povidone-iodine, a tertiary amide, surfactant and coconut oil, useful for killing microbes and treating wounds or sores on the surface of the skin.